A detailed history of British Columbia Investment Management Corp transactions in Pfizer Inc stock. As of the latest transaction made, British Columbia Investment Management Corp holds 945,490 shares of PFE stock, worth $24.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
945,490
Previous 1,081,555 12.58%
Holding current value
$24.6 Million
Previous $30.3 Million 9.58%
% of portfolio
0.17%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $3.77 Million - $4.27 Million
-136,065 Reduced 12.58%
945,490 $27.4 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $10.2 Million - $12 Million
405,144 Added 59.9%
1,081,555 $30.3 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $685,437 - $787,101
26,475 Added 4.07%
676,411 $18.8 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $3.57 Million - $4.64 Million
136,587 Added 26.61%
649,936 $18.7 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $107,212 - $125,320
3,341 Added 0.66%
513,349 $17 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $291,524 - $337,287
8,071 Added 1.61%
510,008 $18.7 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $152,951 - $199,120
3,883 Added 0.78%
501,937 $20.5 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $2.42 Million - $3.16 Million
-57,954 Reduced 10.42%
498,054 $25.5 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $4.26 Million - $5.19 Million
-97,238 Reduced 14.89%
556,008 $24.3 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $9.99 Million - $11.8 Million
-214,641 Reduced 24.73%
653,246 $34.3 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $5.4 Million - $6.7 Million
-118,138 Reduced 11.98%
867,887 $44.9 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $2.03 Million - $3.02 Million
-49,243 Reduced 4.76%
986,025 $58.2 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $98,242 - $126,201
2,503 Added 0.24%
1,035,268 $44.5 Million
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $4.31 Million - $4.88 Million
120,064 Added 13.15%
1,032,765 $40.4 Million
Q1 2021

Apr 30, 2021

SELL
$33.49 - $37.77 $932,026 - $1.05 Million
-27,830 Reduced 2.96%
912,701 $33.1 Million
Q4 2020

Feb 02, 2021

SELL
$33.47 - $42.56 $814,392 - $1.04 Million
-24,332 Reduced 2.52%
940,531 $34.6 Million
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $2.46 Million - $2.88 Million
77,443 Added 8.73%
964,863 $35.4 Million
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $8.5 Million - $10.3 Million
282,074 Added 46.6%
887,420 $29 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $18.9 Million - $27 Million
-699,841 Reduced 53.62%
605,346 $19.8 Million
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $8.88 Million - $10.1 Million
269,671 Added 26.04%
1,305,187 $51.1 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $11.7 Million - $15.2 Million
-360,551 Reduced 25.83%
1,035,516 $37.2 Million
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $484,327 - $543,787
13,097 Added 0.95%
1,396,067 $60.5 Million
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $21.8 Million - $24 Million
-582,202 Reduced 29.63%
1,382,970 $58.7 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $6.72 Million - $7.66 Million
174,697 Added 9.76%
1,965,172 $85.8 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $17.8 Million - $21.7 Million
-517,820 Reduced 22.43%
1,790,475 $78.9 Million
Q2 2018

Aug 09, 2018

SELL
$32.98 - $35.16 $16.8 Million - $17.9 Million
-508,400 Reduced 18.05%
2,308,295 $83.7 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $8.47 Million - $9.83 Million
-265,463 Reduced 8.61%
2,816,695 $100 Million
Q4 2017

Feb 20, 2018

BUY
$33.26 - $35.29 $13.4 Million - $14.2 Million
402,638 Added 15.03%
3,082,158 $112 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $83.1 Million - $91.5 Million
2,679,520
2,679,520 $95.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $146B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.